TIMP1 and ovarian carcinoma: Recently, Będkowska et al. described increased levels of TIMP1 in serum from ovarian cancer patients in comparison with healthy controls, as Maatta et al. previously found in 22 cases of serous, mucinous and others malignant ovarian tumors [32,33].